According to the British Heart Foundation, heart and circulatory diseases cause more than a quarter (27 percent) of all deaths in the UK, which equates to more than 160,000 deaths each year — or one death every three minutes.

Getty Images


May 12, 2021 — According to the British Heart Foundation, heart and circulatory diseases cause more than a quarter (27 percent) of all deaths in the UK, which equates to more than 160,000 deaths each year — or one death every three minutes.

The research, published in the top science journal Advanced Science, found that injection of the trace mineral manganese could enhance MRI scans so that they provided more accurate details of heart function than traditional MRI methods.

These findings, if confirmed in human subjects, could have major implications for the treatment of heart attack patients. The findings could also be of great use in the preclinical evaluation of treatments for patients who suffer from cardiac ischemia — a reduction in blood supply to the heart muscle that could lead to cardiac arrest.

The study also suggests that if manganese-enhanced MRI is performed within the first few hours of a heart attack it could be used to determine the optimal treatment regime for individual patients — helping to regulate changes in the cardiac muscle and thereby further improving survival chances. Findings were evaluated by examining the infarct size and blood supply at three key intervals: one hour, one day and 14 days after a myocardial infarction was induced.

Patrizia Camelliti, M.D., Principal Investigator and Senior Lecturer in Cardiovascular Science at the University of Surrey, said: "Magnetic resonance imaging (MRI) is increasingly used to diagnose and give information on heart conditions. This research using mice allows us to measure the health status of the heart muscle rapidly after a heart attack and could provide important information for optimising treatments in patients."

For more information: http://www.surrey.ac.uk


Related Content

News | Artificial Intelligence

September 25, 2023 — Viz.ai, a leader in AI-powered disease detection and intelligent care coordination, today announced ...

Time September 25, 2023
arrow
Feature | Magnetic Resonance Imaging (MRI) | Robert L. Bard, MD, and Lennard M. Gettz, EdD

Since the advent of the magnetic resonance imaging (MRI) exam on human patients in the late 1970s, this innovation ...

Time September 25, 2023
arrow
News | Prostate Cancer

September 22, 2023 — According to an accepted manuscript published in the American Journal of Roentgenology (AJR) ...

Time September 22, 2023
arrow
News | Cardiac Imaging

September 21, 2023 — Declines in cardiovascular procedure volumes observed early in the COVID-19 pandemic greatly ...

Time September 21, 2023
arrow
News | Contrast Media

September 21, 2023 — Imaging Biometrics, LLC announced the results of a study that validates IB Neuro’s processing of ...

Time September 21, 2023
arrow
News | X-Ray

September 21, 2023 — Scientists in Moscow have successfully engineered a prototype detector for X-ray and PET/CT ...

Time September 21, 2023
arrow
News | Enterprise Imaging

September 20, 2023 — aycan, a recognized leader in medical imaging, announced today a new solution for reviewing DICOM ...

Time September 20, 2023
arrow
Feature | Radiation Dose Management | By Melinda Taschetta-Millane

Early-stage detection is key to the prevention of life-threatening diseases; however, limited access to data hinders the ...

Time September 20, 2023
arrow
Feature | Ultrasound Imaging | By Mustafa Hassan, PhD

Handheld ultrasound has not yet reached mainstream adoption, but the market is still forecast to reach over $500 million ...

Time September 20, 2023
arrow
News | Radiology Business

September 20, 2023 — GE HealthCare released its inaugural Sustainability Report, which describes the steps the company ...

Time September 20, 2023
arrow
Subscribe Now